UCLA Hematologic Malignancy Program — Los Angeles, California

UCLA Hematologic Malignancy Program is a clinical research site located in Los Angeles, California, United States 90024.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Hematologic Malignancy Program has participated in 1 clinical trials.

Therapeutic areas: Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C).

Sponsors: Sun Pharma Advanced Research Company Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

• University of California Los Angeles School of Medicine
• Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
• VA Greater Los Angeles Health System
• Usc/Norris Comprehensive Cancer Center Hospital
• University of Southern California - PT Associates
• University of Southern California Keck School of Medicine/University of Southern California LAC & USC Medical Center
• UCLA Orthodpedic Hospital
• University of Southern California /ID# 164095
• Keck hospital of the University of Southern California
• Los Angeles Orthopedic Hospital, Orthopedic Hemophilia Treatment Center
• University of California Los Angeles - Division of Dermatology
• University California Los Angeles Medical Center (UCLA)

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematologic Malignancy Program?

UCLA Hematologic Malignancy Program has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematologic Malignancy Program conducted?

UCLA Hematologic Malignancy Program has 1 clinical trials on record. Their work covers Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C).

Is UCLA Hematologic Malignancy Program accredited by Crixeo Clinical Trials?

UCLA Hematologic Malignancy Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematologic Malignancy Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.